News

and Press

Sign up now for the latest IR news, and updates on ongoing developments at Avicanna Inc:

    Avicanna Makes RHO Phyto™ Medical Cannabis Products Available In Canadian Hospital Pharmacies Through Agreement with Sunnybrook Hospital
    Avicanna Provides Bi-Weekly Update On Status Of Management Cease Trade Order
    Avicanna Announces Initial Listings and Sales for Evidence-Based RHO Phyto™ Products in Canada’s Adult Use Channels Including Ontario, Manitoba, Saskatchewan, and New Brunswick
    Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update
    Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order
    Avicanna´s Majority Owned Colombian Subsidiary Attains 2021 THC Production Quota and Completes First Commercial Export of Aureus™ Branded THC Active Pharmaceutical Ingredients to Chile
    Avicanna to Participate in Benzinga Biotech Small Cap Conference and the Virtual Life Sciences Investor Forum both taking place on Thursday March 25th
    Avicanna Enters Strategic Partnership with Al Harrington’s, Viola, for commercialization of Viola branded products in Canada
    Avicanna Closes Non-Brokered Private Placement Raising $5.6 Million.
    Avicanna Enters Multi-level Strategic Partnership with Al Harrington’s, Harrington Wellness Inc., to Commercialize re+PLAY™ Branded Products in Canada and the United States
    Avicanna Launches RHO Phyto™ Topical Gels in Canada and Initiates Clinical Studies
    Avicanna Initiates Pre-Clinical and Behavioural Studies on its RHO Phyto™ Formulary with University of Guelph and Provides Research and Management Team Updates